to IMGT/mAb-DB
database logo
1417 entries
1234 -IG
7 -TR
47 -FPIA
68 -CPCA
61 -RPI

IMGT/mAb-DB card

Version: 2.0.4 (2023-04-14)

Citing IMGT/mAb-DB

Manso T., Kushwaha A., Abdollahi N., Duroux P., Giudicelli V. and Kossida S. Mechanisms of action of monoclonal antibodies in oncology integrated in IMGT/mAb-DB. Front Immunol., 14 (2023). DOI 10.3389/fimmu.2023.1129323

Poiron C., Wu Y., Ginestoux C., Ehrenmann, Duroux P. and Lefranc M.-P. IMGT/mAb-DB: the IMGT® database for therapeutic monoclonal antibodies. JOBIM 2010, Paper 13 (2010). Abstract PDF

Cambon M., Cherouali K., Kushwaha A., Giudicelli V., Duroux P., Kossida S. and Lefranc M.-P. IMGT/mAb-DB and IMGT/2Dstructure-DB for IMGT standard definition of an antibody: from receptor to amino acid changes. JOBIM 2018, Poster 201 (2018). Abstract PDF

IMGT/mAb-DB ID 949
INN epcoritamab
INN Number 11078
INN Prop. List 121 (2019)
INN Rec. List 83 (2020)
Common name GEN3013
Proprietary name
Species Homo sapiens
IMGT receptor type IG
Format (legend)
Receptor identification Ig(G1 - kappa_G1 - lambda2)
Radiolabelled / Conjugated / Fused
IMGT/2Dstructure-DB 11078
Specificity target name and species CD3E (CD3e, CD3 epsilon) [Homo sapiens, Chimeric]
MS4A1 (membrane-spanning 4-domains subfamily A member 1, CD20) [Homo sapiens, Chimeric]
bispecific [Homo sapiens, Chimeric]
Development Technology
Origin clone species
Origin clone name

Company Genmab A/S (Copenhagen Denmark)
Expression system CHO (Chinese Hamster Ovary) cells
Application Therapeutic
Clinical domain Oncology
Mechanism of action
Clinical indication B-cell malignancies
Development status
Regulatory agency status and year

    Clinical trials 1 studies found, 1 recruiting
    Authority decisions
      External links
      IMGT notes
      • INN amendment: epcoritamab INN structure is that amended in L123 proposed list (2020) and published in R84 recommended list (2020).
      • INN amendment: epcoritamab INN description is that amended in L127 proposed list (2022) and published in R88 recommended list (2022).
        Format legend:

        © Copyright 1995-2023 IMGT®, the international ImMunoGeneTics information system® | Terms of use | About us | Contact us | Citing IMGT
        European Commission umontpellier CNRS